Topic: M&A / Development

Subject: Question drug development deal structure
Chris Kelly
Member: 2006
Submitted on 07-30-15 10:59 am
Hi team,

I am working with a startup pharmaceutical company that has been approached by a larger partner.
Larger partner has a high quality problem, in that they received $XXX,XXX,XXX upfront payment on a drug that they have late in development.
They have expressed a strong interest in minimizing their current taxable income in structuring a deal with us.

Can anyone speak to this?
How can we front-load R&D expenses this year?
Is it as simple as invoicing them for services Rendered (as opposed to To Be Rendered - prepaid)?

Thanks very much,
Chris Kelly
 No replies